India, Russia Prodded To Do National Surveys Of Multidrug-Resistant TB
This article was originally published in PharmAsia News
India and Russia are considered nations with major problems of multidrug-resistant tuberculosis, but the World Health Organization warned they have no national information on instances of the disease.
You may also be interested in...
Company says it has learnt from gene therapy flop Glybera, and claims best-in-class status for viral vector.
Softening provisions to make EU-wide joint clinical assessments voluntary would make proposed legislation on HTA cooperation redundant, says Eurordis.